SafePAS secures €2.5 million EIS grant to accelerate global rollout of DrugHunter drug-testing analyzer
Estonian deep-tech company SafePAS has been awarded €2.5 million by the Estonian Business and Innovation Agency (EIS) under the European Innovation Council (EIC) Seal of Excellence scheme. The funding will accelerate international growth of DrugHunter, the company’s breakthrough rapid-testing analyzer that delivers on-site, legally defensible drug detection in minutes. DrugHunter enables quantitative, oral-fluid drug testing directly in the field, dramatically reducing the time needed…






